FDA advisers vote to recommend preterm birth drug Makena be removed from market | CNN

  • 📰 CNN
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 95%

United States News News

United States United States Latest News,United States United States Headlines

An FDA advisory committee voted that a drug approved more than a decade ago to reduce the risk of preterm birth should not be allowed to remain on the market after a larger study failed to show that it was effective.

A US Food and Drug Administration advisory committee voted Wednesday that a drug approved more than a decade ago to reduce the risk of preterm birth should not be allowed to remain on the market after a larger study failed to show that it was effective. It’s now up to FDA leaders to make a final decision about whether to remove the drug from the market.

It noted that risk of preterm labor is higher for Black and other minority women and argued that withdrawal of accelerated approval “would have significant negative public health consequences for high-risk pregnant women, including Black and minority women and socially disadvantaged populations.” In a statement after Wednesday’s meeting, Raghav Chari, Covis’ chief innovation officer, said the company believes that “Makena is effective in a higher-risk patient population.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Nice. Now do the Covid💉.

Whoever is approving and disapproving anything is really using us humans as lab rats.

So what are the effects of this drug? Amen

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 4. in US

United States United States Latest News, United States United States Headlines